Adnan Kastrati

Showing 1-20 of 42 articles

Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon

Ndrepepa G, Kastrati A

January 17, 2020 | 10.4244/EIJV15I13A208

Peripheral interventions

Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz K, Ibrahim T

December 20, 2019 | 10.4244/EIJ-D-19-00187

Coronary interventions

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation

Goedel A, Fiedler K, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sarafoff N

October 18, 2019 | 10.4244/EIJ-D-18-00995

Coronary interventions

Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

October 1, 2019 | 10.4244/EIJ-D-19-00488

Coronary interventions

Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss H, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne R, Laugwitz K, Schunkert H, Massberg S, Kastrati A, Mehilli J

September 20, 2019 | 10.4244/EIJ-D-18-00603

Interventions for valvular disease

Hemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr P, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M

September 10, 2019 | 10.4244/EIJ-D-19-00710

Peripheral interventions

Incidence and Predictors of Stent Thrombosis after Endovascular Revascularisation of the Superficial Femoral Artery

Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz K, Ibrahim T

July 30, 2019 | 10.4244/EIJ-D-19-00187

Omission of aspirin after ACS or stenting in patients with oral anticoagulation – why have the goalposts moved?

Byrne R, Colleran R, Kastrati A

April 5, 2019 | 10.4244/EIJV14I18A312

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

February 5, 2019 | 10.4244/EIJ-D-18-01080

No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms

Ndrepepa G, Colleran R, Kastrati A

June 20, 2018 | 10.4244/EIJV14I2A21

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska J, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

Byrne R, Stefanini G, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys P, Windecker S

January 19, 2018 | 10.4244/EIJ20170912-01

Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)

Ott I, Shivaraju A, Schafer N, Frangieh A, Michel J, Husser O, Hengstenberg C, Mayr P, Colleran R, Pellegrini C, Cassese S, Fusaro M, Schunkert H, Kastrati A, Kasel A

October 20, 2017 | 10.4244/EIJ-D-16-01036

Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis

Colleran R, Harada Y, Kufner S, Giacoppo D, Joner M, Cassese S, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

October 20, 2017 | 10.4244/EIJ-D-16-00939

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Coronary interventions

State of the art: coronary artery stents – past, present and future

Stefanini G, Byrne R, Windecker S, Kastrati A

August 25, 2017 | 10.4244/EIJ-D-17-00557

Peripheral interventions

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Interventions for hypertension

Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease

Bradaric C, Eser K, Preuss S, Dommasch M, Wustrow I, Langwieser N, Haller B, Ott I, Fusaro M, Heemann U, Laugwitz K, Kastrati A, Ibrahim T

June 2, 2017 | 10.4244/EIJ-D-16-00697

Coronary interventions

Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique

Harada Y, Colleran R, Pinieck S, Giacoppo D, Michel J, Kufner S, Cassese S, Joner M, Ibrahim T, Laugwitz K, Kastrati A, Byrne R

April 20, 2017 | 10.4244/EIJ-D-16-00226

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Adnan Kastrati

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke